nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Altered state of consciousness—Temozolomide—malignant glioma	0.0486	0.0821	CcSEcCtD
Cyclizine—Speech disorder—Carmustine—malignant glioma	0.027	0.0456	CcSEcCtD
Cyclizine—Speech disorder—Temozolomide—malignant glioma	0.0261	0.0441	CcSEcCtD
Cyclizine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.026	0.093	CbGpPWpGaD
Cyclizine—Injection site reaction—Carmustine—malignant glioma	0.0231	0.039	CcSEcCtD
Cyclizine—Depressed level of consciousness—Carmustine—malignant glioma	0.0224	0.0379	CcSEcCtD
Cyclizine—Depressed level of consciousness—Temozolomide—malignant glioma	0.0217	0.0366	CcSEcCtD
Cyclizine—Thrombophlebitis—Carmustine—malignant glioma	0.0195	0.0329	CcSEcCtD
Cyclizine—Thrombophlebitis—Temozolomide—malignant glioma	0.0188	0.0318	CcSEcCtD
Cyclizine—Clozapine—CALY—malignant glioma	0.0181	0.141	CrCbGaD
Cyclizine—Benzphetamine—POR—malignant glioma	0.0137	0.107	CrCbGaD
Cyclizine—SULT1E1—Phase II conjugation—GSTT1—malignant glioma	0.0135	0.0483	CbGpPWpGaD
Cyclizine—Hepatobiliary disease—Temozolomide—malignant glioma	0.0119	0.0201	CcSEcCtD
Cyclizine—Connective tissue disorder—Carmustine—malignant glioma	0.0115	0.0194	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—CYP2B6—malignant glioma	0.0113	0.0403	CbGpPWpGaD
Cyclizine—Hepatitis—Temozolomide—malignant glioma	0.0113	0.019	CcSEcCtD
Cyclizine—SULT1E1—Metapathway biotransformation—CYP2B6—malignant glioma	0.0111	0.0398	CbGpPWpGaD
Cyclizine—Connective tissue disorder—Temozolomide—malignant glioma	0.0111	0.0187	CcSEcCtD
Cyclizine—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.011	0.0392	CbGpPWpGaD
Cyclizine—Eye disorder—Carmustine—malignant glioma	0.0109	0.0184	CcSEcCtD
Cyclizine—Eye disorder—Temozolomide—malignant glioma	0.0105	0.0178	CcSEcCtD
Cyclizine—Mental disorder—Carmustine—malignant glioma	0.0102	0.0173	CcSEcCtD
Cyclizine—Erythema—Carmustine—malignant glioma	0.0102	0.0172	CcSEcCtD
Cyclizine—Chills—Temozolomide—malignant glioma	0.0101	0.0171	CcSEcCtD
Cyclizine—Mental disorder—Temozolomide—malignant glioma	0.00987	0.0167	CcSEcCtD
Cyclizine—Erythema—Temozolomide—malignant glioma	0.00981	0.0166	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—CYP2C18—malignant glioma	0.00979	0.035	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00966	0.0345	CbGpPWpGaD
Cyclizine—Trimethaphan—BCHE—malignant glioma	0.00964	0.0751	CrCbGaD
Cyclizine—Vision blurred—Carmustine—malignant glioma	0.00957	0.0162	CcSEcCtD
Cyclizine—Tremor—Carmustine—malignant glioma	0.00951	0.0161	CcSEcCtD
Cyclizine—SULT1E1—Phase II conjugation—GSTP1—malignant glioma	0.00938	0.0335	CbGpPWpGaD
Cyclizine—Agitation—Carmustine—malignant glioma	0.00933	0.0158	CcSEcCtD
Cyclizine—Vision blurred—Temozolomide—malignant glioma	0.00925	0.0156	CcSEcCtD
Cyclizine—Tremor—Temozolomide—malignant glioma	0.00919	0.0155	CcSEcCtD
Cyclizine—Agitation—Temozolomide—malignant glioma	0.00901	0.0152	CcSEcCtD
Cyclizine—Angioedema—Temozolomide—malignant glioma	0.00896	0.0151	CcSEcCtD
Cyclizine—Convulsion—Carmustine—malignant glioma	0.0088	0.0149	CcSEcCtD
Cyclizine—Hypertension—Carmustine—malignant glioma	0.00876	0.0148	CcSEcCtD
Cyclizine—Bifonazole—CYP2B6—malignant glioma	0.00857	0.0668	CrCbGaD
Cyclizine—Convulsion—Temozolomide—malignant glioma	0.0085	0.0144	CcSEcCtD
Cyclizine—Hypertension—Temozolomide—malignant glioma	0.00847	0.0143	CcSEcCtD
Cyclizine—Diphenylpyraline—SLC6A3—malignant glioma	0.00846	0.0659	CrCbGaD
Cyclizine—Tachycardia—Carmustine—malignant glioma	0.00809	0.0137	CcSEcCtD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00802	0.0286	CbGpPWpGaD
Cyclizine—Anaphylactic shock—Temozolomide—malignant glioma	0.00801	0.0135	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—GSTT1—malignant glioma	0.00792	0.0283	CbGpPWpGaD
Cyclizine—Nervous system disorder—Temozolomide—malignant glioma	0.00785	0.0133	CcSEcCtD
Cyclizine—Skin disorder—Temozolomide—malignant glioma	0.00778	0.0131	CcSEcCtD
Cyclizine—Hypotension—Carmustine—malignant glioma	0.00774	0.0131	CcSEcCtD
Cyclizine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00767	0.0274	CbGpPWpGaD
Cyclizine—Insomnia—Carmustine—malignant glioma	0.00749	0.0127	CcSEcCtD
Cyclizine—Paraesthesia—Carmustine—malignant glioma	0.00744	0.0126	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—PTGS1—malignant glioma	0.00742	0.0265	CbGpPWpGaD
Cyclizine—Somnolence—Carmustine—malignant glioma	0.00737	0.0124	CcSEcCtD
Cyclizine—Insomnia—Temozolomide—malignant glioma	0.00724	0.0122	CcSEcCtD
Cyclizine—Paraesthesia—Temozolomide—malignant glioma	0.00719	0.0122	CcSEcCtD
Cyclizine—Somnolence—Temozolomide—malignant glioma	0.00712	0.012	CcSEcCtD
Cyclizine—Pain—Carmustine—malignant glioma	0.00708	0.012	CcSEcCtD
Cyclizine—Constipation—Carmustine—malignant glioma	0.00708	0.012	CcSEcCtD
Cyclizine—Flunarizine—CYP2B6—malignant glioma	0.00689	0.0537	CrCbGaD
Cyclizine—Pain—Temozolomide—malignant glioma	0.00685	0.0116	CcSEcCtD
Cyclizine—Constipation—Temozolomide—malignant glioma	0.00685	0.0116	CcSEcCtD
Cyclizine—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00681	0.0243	CbGpPWpGaD
Cyclizine—Benzatropine—SLC6A3—malignant glioma	0.00649	0.0505	CrCbGaD
Cyclizine—Urticaria—Temozolomide—malignant glioma	0.00636	0.0107	CcSEcCtD
Cyclizine—Hypersensitivity—Carmustine—malignant glioma	0.0061	0.0103	CcSEcCtD
Cyclizine—Asthenia—Carmustine—malignant glioma	0.00594	0.01	CcSEcCtD
Cyclizine—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.0059	0.0211	CbGpPWpGaD
Cyclizine—Hypersensitivity—Temozolomide—malignant glioma	0.0059	0.00997	CcSEcCtD
Cyclizine—Asthenia—Temozolomide—malignant glioma	0.00574	0.00971	CcSEcCtD
Cyclizine—Pruritus—Temozolomide—malignant glioma	0.00566	0.00957	CcSEcCtD
Cyclizine—Modafinil—CYP2B6—malignant glioma	0.00563	0.0439	CrCbGaD
Cyclizine—SULT1E1—Metabolism—RTEL1—malignant glioma	0.00555	0.0198	CbGpPWpGaD
Cyclizine—SULT1E1—Biological oxidations—GSTP1—malignant glioma	0.00549	0.0196	CbGpPWpGaD
Cyclizine—Dizziness—Carmustine—malignant glioma	0.00548	0.00926	CcSEcCtD
Cyclizine—Cinnarizine—CYP2B6—malignant glioma	0.00545	0.0425	CrCbGaD
Cyclizine—SULT1E1—Metapathway biotransformation—GSTP1—malignant glioma	0.00541	0.0193	CbGpPWpGaD
Cyclizine—Dizziness—Temozolomide—malignant glioma	0.00529	0.00895	CcSEcCtD
Cyclizine—Diphenhydramine—CYP2C18—malignant glioma	0.00527	0.0411	CrCbGaD
Cyclizine—Headache—Carmustine—malignant glioma	0.00519	0.00877	CcSEcCtD
Cyclizine—Headache—Temozolomide—malignant glioma	0.00502	0.00848	CcSEcCtD
Cyclizine—Benzphetamine—CYP2B6—malignant glioma	0.00488	0.0381	CrCbGaD
Cyclizine—Modafinil—SLC6A3—malignant glioma	0.0048	0.0374	CrCbGaD
Cyclizine—Mianserin—CYP2B6—malignant glioma	0.00474	0.0369	CrCbGaD
Cyclizine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00468	0.0167	CbGpPWpGaD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00445	0.0159	CbGpPWpGaD
Cyclizine—Benzphetamine—SLC6A3—malignant glioma	0.00416	0.0324	CrCbGaD
Cyclizine—Atomoxetine—SLC6A3—malignant glioma	0.00413	0.0322	CrCbGaD
Cyclizine—Mianserin—SLC6A3—malignant glioma	0.00404	0.0315	CrCbGaD
Cyclizine—Diphenhydramine—CYP2B6—malignant glioma	0.00391	0.0305	CrCbGaD
Cyclizine—Orphenadrine—CYP2B6—malignant glioma	0.0037	0.0288	CrCbGaD
Cyclizine—Loxapine—SLC6A3—malignant glioma	0.00321	0.025	CrCbGaD
Cyclizine—SULT1E1—Metabolism—COX8A—malignant glioma	0.00319	0.0114	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00283	0.0101	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00279	0.00997	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ASMT—malignant glioma	0.00271	0.00968	CbGpPWpGaD
Cyclizine—Diphenhydramine—PTGS1—malignant glioma	0.00258	0.0201	CrCbGaD
Cyclizine—SULT1E1—Metabolism—BCAN—malignant glioma	0.00255	0.0091	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00245	0.00876	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00242	0.00864	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00229	0.00819	CbGpPWpGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00215	0.00768	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—BIRC5—malignant glioma	0.00212	0.00758	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—IDH2—malignant glioma	0.00205	0.00734	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00199	0.0071	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP2B6—malignant glioma	0.00193	0.0069	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—BAD—malignant glioma	0.00179	0.00639	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—IDH1—malignant glioma	0.00177	0.00631	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SPHK1—malignant glioma	0.00171	0.0061	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—PTPN11—malignant glioma	0.0017	0.00608	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP2C18—malignant glioma	0.00167	0.00598	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—PIK3CD—malignant glioma	0.00152	0.00544	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00151	0.00538	CbGpPWpGaD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00143	0.00509	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GSTT1—malignant glioma	0.00135	0.00484	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.0013	0.00463	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTGS1—malignant glioma	0.00127	0.00453	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00122	0.00435	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.0012	0.00429	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—BCHE—malignant glioma	0.00118	0.00421	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SLC5A5—malignant glioma	0.00117	0.00416	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00114	0.00407	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00111	0.00397	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00106	0.00377	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.00104	0.00372	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—KNG1—malignant glioma	0.00104	0.0037	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—STAT3—malignant glioma	0.00103	0.00366	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00102	0.00364	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.000963	0.00344	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GSTP1—malignant glioma	0.000939	0.00335	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.000927	0.00331	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CAT—malignant glioma	0.000913	0.00326	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.000881	0.00315	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NCOR1—malignant glioma	0.000863	0.00308	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000854	0.00305	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CCR4—malignant glioma	0.000845	0.00302	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.000825	0.00295	CbGpPWpGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000824	0.00294	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.000822	0.00293	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—PIK3CA—malignant glioma	0.000809	0.00289	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.0008	0.00286	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000755	0.0027	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LATS2—malignant glioma	0.000722	0.00258	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CAV1—malignant glioma	0.000703	0.00251	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000687	0.00245	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—F2—malignant glioma	0.00067	0.00239	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—AKT1—malignant glioma	0.000661	0.00236	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CG—malignant glioma	0.000641	0.00229	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCR3—malignant glioma	0.000628	0.00224	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PPARG—malignant glioma	0.000618	0.00221	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.000599	0.00214	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000598	0.00214	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000592	0.00211	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000584	0.00208	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—BDKRB2—malignant glioma	0.000575	0.00205	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000563	0.00201	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CD—malignant glioma	0.000563	0.00201	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LATS1—malignant glioma	0.000547	0.00196	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—KNG1—malignant glioma	0.000523	0.00187	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CB—malignant glioma	0.000491	0.00175	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTGS2—malignant glioma	0.000486	0.00174	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CCR4—malignant glioma	0.000478	0.00171	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00045	0.00161	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000444	0.00158	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCR4—malignant glioma	0.000434	0.00155	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000428	0.00153	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTEN—malignant glioma	0.000424	0.00151	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000414	0.00148	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MDK—malignant glioma	0.00037	0.00132	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCR3—malignant glioma	0.000355	0.00127	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DTX1—malignant glioma	0.000353	0.00126	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COX8A—malignant glioma	0.000344	0.00123	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—F2—malignant glioma	0.000338	0.00121	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000325	0.00116	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCR3—malignant glioma	0.000322	0.00115	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000313	0.00112	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000309	0.0011	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000307	0.0011	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.0003	0.00107	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CA—malignant glioma	0.000299	0.00107	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—KNG1—malignant glioma	0.000295	0.00106	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—BDKRB2—malignant glioma	0.000295	0.00105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000292	0.00104	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000292	0.00104	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000286	0.00102	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SUFU—malignant glioma	0.00028	0.001	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HEY2—malignant glioma	0.000277	0.000989	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—BCAN—malignant glioma	0.000275	0.000981	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GFAP—malignant glioma	0.00027	0.000966	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KNG1—malignant glioma	0.000268	0.000958	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000268	0.000957	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SPHK1—malignant glioma	0.000262	0.000934	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HEY1—malignant glioma	0.000256	0.000915	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCR4—malignant glioma	0.000256	0.000915	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	0.000249	0.000889	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKT1—malignant glioma	0.000244	0.000873	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCL8—malignant glioma	0.000238	0.000851	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MMP3—malignant glioma	0.000238	0.000849	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JAG2—malignant glioma	0.000227	0.000812	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—IDH2—malignant glioma	0.000221	0.000791	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000209	0.000746	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000208	0.000744	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—H3F3A—malignant glioma	0.000192	0.000687	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—F2—malignant glioma	0.000191	0.000682	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCR3—malignant glioma	0.00019	0.00068	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—IDH1—malignant glioma	0.00019	0.00068	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—YWHAE—malignant glioma	0.000185	0.000662	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NTRK2—malignant glioma	0.000185	0.000662	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FLT1—malignant glioma	0.000184	0.000659	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000184	0.000658	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DUSP6—malignant glioma	0.000184	0.000656	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000183	0.000653	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JAG1—malignant glioma	0.000181	0.000648	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH3—malignant glioma	0.000181	0.000645	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000181	0.000645	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FBXW7—malignant glioma	0.000178	0.000635	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BDKRB2—malignant glioma	0.000174	0.000622	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—F2—malignant glioma	0.000173	0.000619	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00017	0.000608	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT2—malignant glioma	0.000167	0.000597	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	0.000166	0.000593	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTPN11—malignant glioma	0.000163	0.000582	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH2—malignant glioma	0.000162	0.000578	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000161	0.000574	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KNG1—malignant glioma	0.000159	0.000566	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000155	0.000554	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT2—malignant glioma	0.000152	0.000542	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NTRK1—malignant glioma	0.000151	0.00054	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00015	0.000535	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000146	0.000521	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	0.000146	0.000521	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP3—malignant glioma	0.00014	0.000502	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	0.00014	0.0005	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	0.000139	0.000497	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000137	0.000489	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000136	0.000487	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTK2—malignant glioma	0.000135	0.000483	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	0.000135	0.000481	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HES1—malignant glioma	0.000133	0.000474	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCOR1—malignant glioma	0.000132	0.000472	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RAF1—malignant glioma	0.00013	0.000465	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IL2—malignant glioma	0.000129	0.000459	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—BCHE—malignant glioma	0.000127	0.000454	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	0.000127	0.000454	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	0.000126	0.000452	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000126	0.000449	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SPP1—malignant glioma	0.000123	0.000438	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	0.000122	0.000436	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000119	0.000424	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000118	0.00042	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL2—malignant glioma	0.000117	0.000417	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TERT—malignant glioma	0.000116	0.000416	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFB—malignant glioma	0.000114	0.000406	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGFR1—malignant glioma	0.000113	0.000404	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HIF1A—malignant glioma	0.000111	0.000397	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CAV1—malignant glioma	0.000108	0.000384	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KDR—malignant glioma	0.000106	0.00038	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000103	0.000367	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2—malignant glioma	0.000102	0.000366	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FN1—malignant glioma	0.000102	0.000366	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BAD—malignant glioma	0.000101	0.000362	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTP1—malignant glioma	0.000101	0.000361	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	0.0001	0.000358	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAT—malignant glioma	9.85e-05	0.000352	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CD80—malignant glioma	9.82e-05	0.000351	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APC—malignant glioma	9.8e-05	0.00035	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	9.8e-05	0.00035	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGF—malignant glioma	9.69e-05	0.000346	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTPN11—malignant glioma	9.63e-05	0.000344	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOR1—malignant glioma	9.3e-05	0.000332	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BRAF—malignant glioma	9.22e-05	0.000329	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT2—malignant glioma	8.97e-05	0.00032	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EGFR—malignant glioma	8.93e-05	0.000319	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	8.62e-05	0.000308	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	8.54e-05	0.000305	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KRAS—malignant glioma	8.44e-05	0.000301	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF2—malignant glioma	8.25e-05	0.000295	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	7.75e-05	0.000277	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MDM2—malignant glioma	7.72e-05	0.000276	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RAF1—malignant glioma	7.69e-05	0.000275	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ERBB2—malignant glioma	7.61e-05	0.000272	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAV1—malignant glioma	7.58e-05	0.000271	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	7.51e-05	0.000268	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.24e-05	0.000259	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL8—malignant glioma	7.22e-05	0.000258	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	6.97e-05	0.000249	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASP3—malignant glioma	6.91e-05	0.000247	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.91e-05	0.000247	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL2—malignant glioma	6.9e-05	0.000246	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—malignant glioma	6.67e-05	0.000238	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—malignant glioma	6.53e-05	0.000233	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTEN—malignant glioma	6.49e-05	0.000232	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—malignant glioma	6.33e-05	0.000226	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.07e-05	0.000217	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—malignant glioma	5.86e-05	0.000209	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT3—malignant glioma	5.81e-05	0.000207	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MYC—malignant glioma	5.39e-05	0.000193	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.29e-05	0.000189	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGFR—malignant glioma	5.28e-05	0.000188	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—malignant glioma	5.24e-05	0.000187	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KRAS—malignant glioma	4.98e-05	0.000178	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	4.58e-05	0.000164	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTEN—malignant glioma	4.57e-05	0.000163	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—malignant glioma	4.43e-05	0.000158	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—malignant glioma	3.74e-05	0.000134	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.23e-05	0.000115	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—malignant glioma	2.64e-05	9.41e-05	CbGpPWpGaD
